# EDGAR Filing Document

**Accession Number:** 0001847846
**File Stem:** 0001493152-25-023883
**Filing Date:** 2025-11
**Character Count:** 6600
**Document Hash:** 3a22c103a78dc20ea612be7c2c2de8e5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-25-023883.hdr.sgml**: 20251117

**ACCESSION NUMBER**: 0001493152-25-023883

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251117

**FILED AS OF DATE**: 20251117

**DATE AS OF CHANGE**: 20251117

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** EUDA Health Holdings Ltd
- **CENTRAL INDEX KEY:** 0001847846
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HEALTH SERVICES [8000]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** D8
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40678
- **FILM NUMBER:** 251491424

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 60 KAKI BUKIT PLACE, #03-01
- **CITY:** EUNOS TECHPARK
- **PROVINCE COUNTRY:** U0
- **ZIP:** 415979
- **BUSINESS PHONE:** 65 67880388

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 60 KAKI BUKIT PLACE, #03-01
- **CITY:** EUNOS TECHPARK
- **PROVINCE COUNTRY:** U0
- **ZIP:** 415979

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** 8i Acquisition 2 Corp.
- **DATE OF NAME CHANGE:** 20210224

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**Form 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER**

**PURSUANT TO RULE 13a-16 OR 15d-16**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

**For the month of November 2025**

**Commission File Number: 001-40678**

**EUDA Health Holdings Limited**

(Exact Name of Registrant as Specified in its Charter)

60 Kaki Bukit Place, #03-01 Eunos Techpark, Singapore 415979

(Address of Principal Executive Offices and Zip Code)

Registrant's telephone number, including area code: +65 6327 1110

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐

As previously disclosed, EUDA Health Holdings Limited ("EUDA" or the "Company") entered into a convertible promissory note purchase agreement dated as of August 1, 2025 (the "Purchase Agreement") with an institutional investor (the "Purchaser") to purchase one or more convertible promissory notes (the "Notes") in an aggregate amount not to exceed $10,000,000. Pursuant to the Purchase Agreement, the Company issued and sold to the Purchaser an initial Note in the aggregate principal amount of $1,000,000 on August 1, 2025 (the "August Note") which was convertible into newly-issued ordinary shares of the Company, no par value (the "ordinary shares") at 85% of the trading price of the Company's ordinary shares on the date the Purchaser submits its conversion notice. Prior to September 19, 2025, the Purchaser had converted an aggregate of $837,500 of the August Note into 569,859 ordinary shares.

As previously disclosed, pursuant to a letter agreement by the parties dated September 19, 2025 which was further amended on October 2, 2025, the Company delivered to the Purchaser an additional 41,620 ordinary shares at the conversion price of $0.901 per share, and the Purchaser agreed not to convert the remaining $162,500 balance of the August Note until after October 31, 2025 on which date the Purchaser may opt to either convert the remaining $162,500 balance of the August Note into 81,250 ordinary shares at $2.00 per share, or request that the Company repay the $162,500 in cash. On November 7, 2025, the Purchaser agreed to convert the remaining $162,500 balance of the August Note into 81,250 ordinary shares (the "October Amendment to Letter Agreement").

As previously disclosed, the Company does not intend to send Purchaser any additional put requests for the sale of additional Notes to the Purchaser under the terms of the Purchase Agreement.

The foregoing description of the October Amendment to Letter Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the October Amendment to Letter Agreement which is filed as Exhibit 1.1 to this Current Report, and incorporated by reference herein.

This Report on Form 6-K is incorporated by reference into the Company's Registration Statement on [Form F-3](https://www.sec.gov/Archives/edgar/data/1847846/000149315224041563/formf-3.htm) (File No. 333-282723) and the prospectus thereof and any prospectus supplements or amendments thereto.

---

| | |
|:---|:---|
| **Exhibits** |  |
| **1.1** | [October Amendment to Letter Agreement.](ex1-1.htm) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

---

| | |
|:---|:---|
| Dated: November 17, 2025 | Dated: November 17, 2025 |
| **EUDA Health Holdings Limited** | **EUDA Health Holdings Limited** |
|  | */s/ Alfred Lim* |
| By: | Alfred Lim |
|  | Chief Executive Officer |

---

## Exhibit 1.1

**Exhibit 1.1**

November 7, 2025

Mr. George Sandhu

Managing Director

Indigo Capital LP

89 Nexus Way

Caymana Bay, Cayman Islands

Re: August 1, 2025 EUDA Health Holdings Ltd. (the "Company") Promissory Note (the "Note") and August 1, 2025 Convertible Promissory Note Agreement (the "Agreement") between Indigo Capital, LP ("Indigo") and the Company.

Dear Mr. Sandhu:

I write to confirm our third amendment with respect to the Note which shall amend the first amendment dated September 19, 2025 (the "First Amendment") and second amendment dated October 2, 2025 (the "Second Amendment").

Indigo hereby agrees that it will convert the entire remaining balance of the Note into 81,250 Company common shares at $2.00 per share within three business days of the date of this Third Amendment (the "Conversion"). The Company agrees that it shall instruct its stock transfer agent, Equiniti Trust Company, LLC ("Equiniti"), to accept the Conversion within one business day of receipt by the Company and Equiniti.

All other terms of the Note, Agreement, First Amendment and Second Amendment shall remain unchanged except as set forth above.

Please sign below to acknowledge your agreement to these terms.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| EUDA HEALTH HOLDINGS LTD. | EUDA HEALTH HOLDINGS LTD. |
| By: | */s/ Alfred Lim, CEO* |
|  | Alfred Lim, CEO |

---

---

| | |
|:---|:---|
| ACKNOWLEDGED AND AGREED: INDIGO CAPITAL, LP | ACKNOWLEDGED AND AGREED: INDIGO CAPITAL, LP |
| By: | */s/ George Sandhu* |
|  | George Sandhu |
|  | Managing Director |

---